NCT01841723 2026-03-18
Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Baylor College of Medicine
Children's Oncology Group
City of Hope Medical Center
UNICANCER
Thomas Jefferson University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)